Wendy M. Martens

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.

Journal: Breast cancer research and treatment

Published: December 16, 2022

A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer.

A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer.

Journal: Biochemical pharmacology

Published: June 10, 2022

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer.

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer.

Journal: Cancer & metabolism

Published: May 24, 2022

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Journal: ESMO open

Published: November 16, 2021

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients.

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients.

Journal: Frontiers in oncology

Published: April 19, 2021

Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction.

Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction.

Journal: BMC cancer

Published: August 27, 2020

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.

Journal: BMC cancer

Published: March 13, 2020

Characterizing the invasion of different breast cancer cell lines with distinct E-cadherin status in 3D using a microfluidic system.

Characterizing the invasion of different breast cancer cell lines with distinct E-cadherin status in 3D using a microfluidic system.

Journal: Biomedical microdevices

Published: November 25, 2019

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

Journal: Scientific reports

Published: March 01, 2018

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.

Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.

Journal: Neoplasia (New York, N.Y.)

Published: February 06, 2018

Showing 1-12 of 35

Last Updated: 09/26/2026